Healthcare seeking outside healthcare facilities and antibiotic dispensing patterns in rural Burkina Faso: A mixed methods study.

Burkina Faso antibiotic use antimicrobial resistance community setting cross-sectional studies healthcare utilisation informal drug outlets mixed methods sub-Saharan Africa

Journal

Tropical medicine & international health : TM & IH
ISSN: 1365-3156
Titre abrégé: Trop Med Int Health
Pays: England
ID NLM: 9610576

Informations de publication

Date de publication:
05 2023
Historique:
medline: 5 5 2023
pubmed: 6 3 2023
entrez: 5 3 2023
Statut: ppublish

Résumé

Optimising antibiotic use is important to limit increasing antibiotic resistance. In rural Burkina Faso, over-the-counter dispensing of antibiotics in community pharmacies and non-licensed medicine retail outlets facilitates self-medication. We investigated its extent, reasons and dispensing patterns. In an exploratory mixed-method design conducted between October 2020 and December 2021, this study first explored illness perceptions, the range of healthcare providers in communities, antibiotics knowledge and reasons for seeking healthcare outside healthcare facilities. Second, frequencies of illness and healthcare utilisation in the last 3 months were quantitatively measured. Participants distinguished between natural and magico-religious illnesses, according to origins. For illnesses considered to be 'natural', healthcare was mainly sought at healthcare facilities, private pharmacies and informal drug outlets. For illnesses considered as magico-religious, traditional healers were mainly visited. Antibiotics were perceived in the community as medicines similar to painkillers. Healthcare-seeking outside healthcare facilities was reported by 660/1973 (33.5%) participants reporting symptoms, including 315 (47.7%) to informal vendors. Healthcare seeking outside facilities was less common for 0-4-year-olds (58/534, 10.9% vs. 379/850, 44.1% for ≥5-year-olds) and decreased with improving socio-economic status (108/237, 45.6% in the lowest quintile; 96/418, 23.0% in the highest). Reported reasons included financial limitation, and also proximity to informal drug vendors, long waiting times at healthcare facilities, and health professionals' non-empathetic attitudes towards their patients. This study highlights the need to facilitate and promote access to healthcare facilities through universal health insurance and patient-centred care including reducing patients' waiting time. Furthermore, community-level antibiotic stewardship programmes should include community pharmacies and informal vendors.

Identifiants

pubmed: 36871194
doi: 10.1111/tmi.13868
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

391-400

Informations de copyright

© 2023 The Authors Tropical Medicine & International Health Published by John Wiley & Sons Ltd.

Références

Booton RD, Meeyai A, Alhusein N, Buller H, Feil E, Lambert H, et al. One health drivers of antibacterial resistance: quantifying the relative impacts of human, animal and environmental use and transmission. One Health. 2021;12:100220.
Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629-55.
Cassini A, Högberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56-66.
Malik B, Bhattacharyya S. Antibiotic drug-resistance as a complex system driven by socio-economic growth and antibiotic misuse. Sci Rep. 2019;9(1):1-12.
Afari-Asiedu S, Oppong FB, Tostmann A, Ali Abdulai M, Boamah-Kaali E, Gyaase S, et al. Determinants of inappropriate antibiotics use in rural Central Ghana using a mixed methods approach. Front Public Health. 2020;8:1-11.
Wulandari LPL, Khan M, Liverani M, Ferdiana A, Mashuri YA, Probandari A, et al. Prevalence and determinants of inappropriate antibiotic dispensing at private drug retail outlets in urban and rural areas of Indonesia: a mixed methods study. BMJ Glob Health. 2021;6(8):1-11.
Ahiabu MA, Tersbøl BP, Biritwum R, Bygbjerg IC, Magnussen P. A retrospective audit of antibiotic prescriptions in primary health-care facilities in Eastern Region, Ghana. Health Policy Plan. 2016;31(2):250-8.
Bonko MDA, Kiemde F, Tahita MC, Lompo P, Some AM, Tinto H, et al. The effect of malaria rapid diagnostic tests results on antimicrobial prescription practices of health care workers in Burkina Faso. Ann Clin Microbiol Antimicrob. 2019;18(1):1-9. https://doi.org/10.1186/s12941-019-0304-2
Keitel K, Kagoro F, Samaka J, Masimba J, Said Z, Temba H, et al. A novel electronic algorithm using host biomarker point-of-care tests for the management of febrile illnesses in Tanzanian children (e-POCT): a randomized, controlled non-inferiority trial. PLoS Med. 2017;14(10):1-29.
O'Neill J. Antimicrobial resistance: tackling a crisis for the health and wealth of nations. The Review on Antimicrobial Resistance. 2014.
Assemblée nationale du Burkina Faso. Loi n° 23/94/ADP portant Code de la Santé publique. 1994. p. 1-35.
Ministère de la santé Burkina Faso. Plan stratégique pharmaceutique 2019-2023. 2019.
Ministère de la Santé du Burkina Faso. Plan d'action national multisectoriel de lutte contre la resistance aux antimicrobiens. 2017. 85 p.
Sana B, Kaboré A, Ouédraogo AS, Ibrahim Traoré OO, Saybou S, Semdé R. Revue de la politique et du cadre réglementaire de l'optimisation de la gestion des antimicrobiens au Burkina Faso. PAMJ One Health. 2021;4(16):1-10.
Valia D, Ingelbeen B, Kaboré B, Karama I, Peeters M, Lompo P, et al. Use of WATCH antibiotics prior to presentation to the hospital in rural Burkina Faso. Antimicrob Resist Infect Control. 2022;11(1):59. https://doi.org/10.1186/s13756-022-01098-8
Demissie F, Ereso K, Paulos G. Self-medication practice with antibiotics and its associated factors among community of Bule-Hora Town, South West Ethiopia. Drug Healthc Patient Saf. 2022;14:9-18.
Do NTT, Vu HTL, Nguyen CTK, Punpuing S, Khan WA, Gyapong M, et al. Community-based antibiotic access and use in six low-income and middle-income countries: a mixed-method approach. Lancet Glob Health. 2021;9(5):e610-9.
Belachew SA, Hall L, Erku DA, Selvey LA. No prescription? No problem: drivers of non-prescribed sale of antibiotics among community drug retail outlets in low and middle income countries: a systematic review of qualitative studies. BMC Public Health. 2021;21(1):1-13.
Bonko MDA, Lompo P, Tahita MC, Kiemde F, Karama I, Somé AM, et al. Antibiotic susceptibility of staphylococcus aureus and streptococcus pneumoniae isolates from the nasopharynx of febrile children under 5 years in Nanoro, Burkina Faso. Antibiotics. 2021;10(4):1-10.
Bonko M, dit A, Tahita MC, Kiemde F, Lompo P, Yougbaré S, et al. Antibiotic susceptibility profile of bacterial isolates from febrile children under 5 years of age in Nanoro, Burkina Faso. Trop Med Int Health. 2021;26(10):1220-30.
Salami O, Horgan P, Moore CE, Giri A, Sserwanga A, Pathak A, et al. Impact of a package of diagnostic tools, clinical algorithm, and training and communication on outpatient acute fever case management in low- and middle-income countries: protocol for a randomized controlled trial. Trials. 2020;21(1):1-13.
Derra K, Rouamba E, Kazienga A, Ouedraogo S, Tahita MC, Sorgho H, et al. Profile: Nanoro health and demographic surveillance system. Int J Epidemiol. 2012;41(5):1293-301.
Ministère de la santé/Burkina Faso. PLAN D' ACTON 2018 du District Sanitaire de Nanoro. 2018.
Maltha J, Guiraud I, Kaboré B, Lompo P, Ley B, Bottieau E, et al. Frequency of severe malaria and invasive bacterial infections among children admitted to a rural hospital in Burkina Faso. PLoS One. 2014;9(2):1-8.
Guiraud I, Post A, Diallo SN, Lompo P, Maltha J, Thriemer K, et al. Population-based incidence, seasonality and serotype distribution of invasive salmonellosis among children in Nanoro, rural Burkina Faso. PLoS One. 2017;12:e0178577.
Palinkas LA, Horwitz SM, Green CA, Wisdom JP, Duan N, Hoagwood K. Purposeful sampling for qualitative data collection and analysis in mixed method implementation research. Adm Policy Ment Health. 2015;42(5):533-44. https://doi.org/10.1007/s10488-013-0528-y
Rutstein S. Steps to construct new DHS Wealth Index. Wealth Index Constr. 2020;6:6. Available from: https://www.dhsprogram.com/programming/wealth_index/Steps_to_constructing_the_new_DHS_Wealth_Index.pdf
Ouedraogo AS, Sanou M, Kissou A, Sanou S, Solaré H, Kaboré F, et al. High prevalence of extended-spectrum ß-lactamase producing enterobacteriaceae among clinical isolates in Burkina Faso. BMC Infect Dis. 2016;16(1):1-9. https://doi.org/10.1186/s12879-016-1655-3
Dembélé R, Konaté A, Traoré O, Kaboré WAD, Soulama I, Kagambèga A, et al. Extended spectrum beta-lactamase and fluoroquinolone resistance genes among Escherichia coli and Salmonella isolates from children with diarrhea, Burkina Faso. BMC Pediatr. 2020;20(1):1-9.
Belachew SA, Hall L, Selvey LA. Community drug retail outlet staff's knowledge, attitudes and practices towards non-prescription antibiotics use and antibiotic resistance in the Amhara region, Ethiopia with a focus on non-urban towns. Antimicrob Resist Infect Control. 2022;11:1-14. https://doi.org/10.1186/s13756-022-01102-1
Om C, Daily F, Vlieghe E, McLaughlin JC, McLaws ML. Pervasive antibiotic misuse in the Cambodian community: antibiotic-seeking behaviour with unrestricted access. Antimicrob Resist Infect Control. 2017;6(1):1-8.
Yeika EV, Ingelbeen B, Kemah BL, Wirsiy FS, Fomengia JN, van der Sande MAB. Comparative assessment of the prevalence, practices and factors associated with self-medication with antibiotics in Africa. Trop Med Int Health. 2021;26(8):862-81.
Shi L, Lee DC, Liang H, Zhang L, Makinen M, Blanchet N, et al. Community health centers and primary care access and quality for chronically-ill patients - a case-comparison study of urban Guangdong Province, China. Int J Equity Health. 2015;14(1):1-17. https://doi.org/10.1186/s12939-015-0222-7
Mustafa A, Shekhar C. Is quality and availability of facilities at primary health centers (PHCs) associated with healthcare-seeking from PHCs in rural India: an exploratory cross-sectional analysis. Clin Epidemiol Glob Health. 2021;9:293-8. https://doi.org/10.1016/j.cegh.2020.10.001
Toscos T, Carpenter M, Flanagan M, Kunjan K, Doebbeling BN. Identifying successful practices to overcome access to care challenges in community health centers. Health Serv Res Manag Epidemiol. 2018;5:233339281774340.
Tonkin-Crine SKG, Tan PS, van Hecke O, Wang K, Roberts NW, Mccullough A, et al. Clinician-targeted interventions to influence antibiotic prescribing behaviour for acute respiratory infections in primary care: an overview of systematic reviews. Cochrane Database Syst Rev. 2017;2017(9):1-42.
Waterfield T, Maney JA, Hanna M, Fairley D, Shields MD. Point-of-care testing for procalcitonin in identifying bacterial infections in young infants: a diagnostic accuracy study. BMC Pediatr. 2018;18(1):1-6.
Wertheim HFL, Chuc NTK, Punpuing S, Khan WA, Gyapong M, Asante KP, et al. Community-level antibiotic access and use (ABACUS) in low- and middle-income countries: finding targets for social interventions to improve appropriate antimicrobial use - an observational multi-centre study. Wellcome Open Res. 2017;2:1-13.
Ingelbeen B, Phanzu DM, Phoba M-F, Budiongo MYN, Berhe NM, Kamba FK, et al. Antibiotic use from formal and informal healthcare providers in the Democratic Republic of Congo: a population-based study in two health zones. Clin Microbiol Infect. 2022;28:1272-7.

Auteurs

Daniel Valia (D)

Institut de Recherche en Sciences de la Santé, Direction Régionale du Centre-Ouest/Clinical Research Unit of Nanoro, Nanoro, Burkina Faso.
Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
Epidemiology and Biostatistics Unit, Institut de recherche expérimentale et clinique, Université catholique de Louvain, Brussels, Belgium.

Juste Stéphane Kouanda (JS)

Institut de Recherche en Sciences de la Santé, Direction Régionale du Centre-Ouest/Clinical Research Unit of Nanoro, Nanoro, Burkina Faso.

Brecht Ingelbeen (B)

Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
Julius Center, University Medical Center Utrecht, Utrecht, The Netherlands.

Karim Derra (K)

Institut de Recherche en Sciences de la Santé, Direction Régionale du Centre-Ouest/Clinical Research Unit of Nanoro, Nanoro, Burkina Faso.

Bérenger Kaboré (B)

Institut de Recherche en Sciences de la Santé, Direction Régionale du Centre-Ouest/Clinical Research Unit of Nanoro, Nanoro, Burkina Faso.

François Kiemdé (F)

Institut de Recherche en Sciences de la Santé, Direction Régionale du Centre-Ouest/Clinical Research Unit of Nanoro, Nanoro, Burkina Faso.

Toussaint Rouamba (T)

Institut de Recherche en Sciences de la Santé, Direction Régionale du Centre-Ouest/Clinical Research Unit of Nanoro, Nanoro, Burkina Faso.

Eli Rouamba (E)

Institut de Recherche en Sciences de la Santé, Direction Régionale du Centre-Ouest/Clinical Research Unit of Nanoro, Nanoro, Burkina Faso.

Franck Sovi Hien (FS)

Institut de Recherche en Sciences de la Santé, Direction Régionale du Centre-Ouest/Clinical Research Unit of Nanoro, Nanoro, Burkina Faso.

Linda Campbell (L)

Centre for Population, Family and Health, University of Antwerp, Antwerp, Belgium.
Department for Public Health and Primary Care, University of Ghent, Ghent, Belgium.

Marie Meudec (M)

Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.

Annie Robert (A)

Epidemiology and Biostatistics Unit, Institut de recherche expérimentale et clinique, Université catholique de Louvain, Brussels, Belgium.

Halidou Tinto (H)

Institut de Recherche en Sciences de la Santé, Direction Régionale du Centre-Ouest/Clinical Research Unit of Nanoro, Nanoro, Burkina Faso.
Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.

Marianne A B van der Sande (MAB)

Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
Julius Center, University Medical Center Utrecht, Utrecht, The Netherlands.

Hector Rodriguez Villalobos (HR)

Microbiology Unit, Institut de recherche expérimentale et clinique, Université catholique de Louvain, Brussels, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH